743 related articles for article (PubMed ID: 17925066)
1. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
2. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
3. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
4. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
6. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
Metzger NL; Kockler DR; Gravatt LA
Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
8. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
9. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
Beeh KM; Beier J
Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
[TBL] [Abstract][Full Text] [Related]
10. Risk versus benefit considerations for the beta(2)-agonists.
Kelly HW
Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
12. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
Korsgaard J; Ledet M
Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
[TBL] [Abstract][Full Text] [Related]
13. [Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):889-91. PubMed ID: 16686087
[TBL] [Abstract][Full Text] [Related]
14. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
15. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
17. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
Chung LP; Waterer G; Thompson PJ
Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
[TBL] [Abstract][Full Text] [Related]
20. A safety review of long-acting beta2-agonists in patients with asthma.
Rider NL; Craig TJ
J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
